$CLIR
ClearSign Technologies Corp

2023 Q1 Form 10-K Financial Statement

#000155837023005285 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $894.0K $50.00K $374.0K
YoY Change -7.41% -38.39%
Cost Of Revenue $788.0K $57.00K $258.0K
YoY Change 11.76% -75.64%
Gross Profit $106.0K -$7.000K $116.0K
YoY Change -333.33% -125.66%
Gross Profit Margin 11.86% -14.0% 31.02%
Selling, General & Admin $1.650M $1.386M $5.728M
YoY Change 17.1% 40.85% 14.26%
% of Gross Profit 1556.6% 4937.93%
Research & Development $160.0K $112.0K $505.0K
YoY Change 48.15% -54.1% -81.16%
% of Gross Profit 150.94% 435.34%
Depreciation & Amortization $40.00K $48.00K $161.0K
YoY Change 11.11% 6.67% -38.08%
% of Gross Profit 37.74% 138.79%
Operating Expenses $1.810M $1.498M $6.233M
YoY Change 19.31% 21.99% -18.98%
Operating Profit -$1.704M -$1.505M -$6.117M
YoY Change 12.33% 22.86% -24.9%
Interest Expense $58.00K $48.00K $83.00K
YoY Change 4700.0% 8200.0%
% of Operating Profit
Other Income/Expense, Net $275.0K $138.0K $359.0K
YoY Change 6775.0% -44.35% 42.46%
Pretax Income -$1.429M -$1.318M -$5.758M
YoY Change -4.09% 7.42% -27.04%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.429M -$1.318M -$5.758M
YoY Change -4.09% 7.42% -27.03%
Net Earnings / Revenue -159.84% -2636.0% -1539.57%
Basic Earnings Per Share -$0.04 -$0.03 -$0.16
Diluted Earnings Per Share -$0.04 -$0.03 -$0.16
COMMON SHARES
Basic Shares Outstanding 38.54M 38.02M 35.34M
Diluted Shares Outstanding 38.26M 35.34M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.489M $9.057M $9.057M
YoY Change 27.33% 19.06% 19.06%
Cash & Equivalents $5.328M $6.451M $6.451M
Short-Term Investments $3.161M $2.606M $2.606M
Other Short-Term Assets $317.0K $577.0K $577.0K
YoY Change -20.95% 67.25% 67.25%
Inventory
Prepaid Expenses
Receivables $50.00K $79.00K $99.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.860M $9.733M $9.733M
YoY Change 20.72% 21.3% 21.3%
LONG-TERM ASSETS
Property, Plant & Equipment $515.0K $384.0K $384.0K
YoY Change 4.46% -27.55% -27.55%
Goodwill
YoY Change
Intangibles $782.0K $798.0K
YoY Change -2.49% -0.13%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $1.307M $1.192M $1.192M
YoY Change 0.15% -10.98% -10.98%
TOTAL ASSETS
Total Short-Term Assets $8.860M $9.733M $9.733M
Total Long-Term Assets $1.307M $1.192M $1.192M
Total Assets $10.17M $10.93M $10.93M
YoY Change 17.62% 16.68% 16.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $398.0K $296.0K $296.0K
YoY Change 35.37% 32.14% 32.14%
Accrued Expenses $253.0K $471.0K $604.0K
YoY Change 29.08% 116.06% 42.79%
Deferred Revenue $639.0K $247.0K
YoY Change 660.71% 194.05%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.367M $1.147M $1.147M
YoY Change 73.92% 56.91% 56.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $213.0K $226.0K $226.0K
YoY Change -27.55% -35.43% -35.43%
Total Long-Term Liabilities $213.0K $226.0K $226.0K
YoY Change -27.55% -35.43% -35.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.367M $1.147M $1.147M
Total Long-Term Liabilities $213.0K $226.0K $226.0K
Total Liabilities $1.580M $1.373M $1.373M
YoY Change 46.3% 27.01% 27.01%
SHAREHOLDERS EQUITY
Retained Earnings -$90.00M -$88.50M
YoY Change 6.76% 6.93%
Common Stock $4.000K $4.000K
YoY Change 33.33% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.587M $9.552M $9.552M
YoY Change
Total Liabilities & Shareholders Equity $10.17M $10.93M $10.93M
YoY Change 17.62% 16.68% 16.68%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$1.429M -$1.318M -$5.758M
YoY Change -4.09% 7.42% -27.03%
Depreciation, Depletion And Amortization $40.00K $48.00K $161.0K
YoY Change 11.11% 6.67% -38.08%
Cash From Operating Activities -$554.0K -$728.0K -$4.992M
YoY Change -63.14% -37.51% -25.57%
INVESTING ACTIVITIES
Capital Expenditures $24.00K $45.00K $10.00K
YoY Change 380.0% -157.69% -86.3%
Acquisitions
YoY Change
Other Investing Activities -$530.0K $1.341M -$2.522M
YoY Change -2404.35%
Cash From Investing Activities -$554.0K $1.296M -$2.686M
YoY Change 3593.33% -1761.54% 1161.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.539M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.00K 0.000 6.539M
YoY Change -102.6% 14.84%
NET CHANGE
Cash From Operating Activities -554.0K -728.0K -4.992M
Cash From Investing Activities -554.0K 1.296M -2.686M
Cash From Financing Activities -15.00K 0.000 6.539M
Net Change In Cash -1.123M 568.0K -1.156M
YoY Change 19.47% -145.7% -5.01%
FREE CASH FLOW
Cash From Operating Activities -$554.0K -$728.0K -$4.992M
Capital Expenditures $24.00K $45.00K $10.00K
Free Cash Flow -$578.0K -$773.0K -$5.002M
YoY Change -61.67% -28.89% -26.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M16D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y0M4D
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001434524
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38023701
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31581666
CY2021 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2022 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpense
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-35521
CY2022 dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORPORATION
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
8023 East 63rd Place, Suite 101
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
CY2022 dei City Area Code
CityAreaCode
918
CY2022 dei Local Phone Number
LocalPhoneNumber
236-6461
CY2022 dei Security12b Title
Security12bTitle
Common Stock
CY2022 dei Trading Symbol
TradingSymbol
CLIR
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
36386780
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38541806
CY2022 dei Auditor Firm
AuditorFirmId
207
CY2022 dei Auditor Name
AuditorName
BPM CPA LLP
CY2022 dei Auditor Location
AuditorLocation
Santa Monica, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6451000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7607000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2606000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
79000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
577000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
345000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9733000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8024000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
798000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2022Q4 us-gaap Assets
Assets
10925000
CY2021Q4 us-gaap Assets
Assets
9363000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
296000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
224000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
133000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
471000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
247000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1147000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
731000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
226000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q4 us-gaap Liabilities
Liabilities
1373000
CY2021Q4 us-gaap Liabilities
Liabilities
1081000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38023701
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581666
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98079000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91035000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88523000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82765000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9552000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10925000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9363000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
374000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
607000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
258000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1059000
CY2022 us-gaap Gross Profit
GrossProfit
116000
CY2021 us-gaap Gross Profit
GrossProfit
-452000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
505000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2680000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5728000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5013000
CY2022 us-gaap Operating Expenses
OperatingExpenses
6233000
CY2021 us-gaap Operating Expenses
OperatingExpenses
7693000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-6117000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-8145000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
83000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000
CY2022 clir Governmental Assistance Income
GovernmentalAssistanceIncome
232000
CY2021 clir Governmental Assistance Income
GovernmentalAssistanceIncome
251000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
38000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
359000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
253000
CY2022 us-gaap Profit Loss
ProfitLoss
-5758000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5758000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7891000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35338712
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35338712
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31230806
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31230806
CY2022 us-gaap Profit Loss
ProfitLoss
-5758000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-17000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
9000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5775000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7883000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2022 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2022 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
95000
CY2022 clir Stock Options Granted In Payment Of Accrued Compensation Fair Value
StockOptionsGrantedInPaymentOfAccruedCompensationFairValue
12000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
373000
CY2022 clir Share Issued For At Market Issuance1.24 Per Share
ShareIssuedForAtMarketIssuance1.24PerShare
1.24
CY2022 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
587000
CY2022 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2022 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
0.66
CY2022 clir Stock Issued During Period Value Issued For Services Four
StockIssuedDuringPeriodValueIssuedForServicesFour
1000
CY2022Q4 clir Shares Issued Stock Offering Price Per Share
SharesIssuedStockOfferingPricePerShare
1.11
CY2022 clir Stock Issued During Period Value Stock Offering
StockIssuedDuringPeriodValueStockOffering
4211000
CY2022 clir Shares Issued Pursuant To Purchase Right Price Per Share
SharesIssuedPursuantToPurchaseRightPricePerShare
1.11
CY2022 clir Shares Issued Pursuant To Purchase Right1.11 Per Share
SharesIssuedPursuantToPurchaseRight1.11PerShare
1741000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17000
CY2022 us-gaap Profit Loss
ProfitLoss
-5758000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9552000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021 clir Share Issued For At Market Issuance5.03 Per Share
ShareIssuedForAtMarketIssuance5.03PerShare
5.03
CY2021 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
5309000
CY2021 clir Common Stock Issued For Exercise Of Options3.80 Per Share
CommonStockIssuedForExerciseOfOptions3.80PerShare
3.80
CY2021 clir Stock Issued During Period Value Stock Options Exercised3.80 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.80PerShare
36000
CY2021 clir Common Stock Issued For Exercise Of Options3.10 Per Share
CommonStockIssuedForExerciseOfOptions3.10PerShare
3.10
CY2021 clir Stock Issued During Period Value Stock Options Exercised3.10 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.10PerShare
54000
CY2021Q4 clir Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
26000
CY2021 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2021 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2021 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
12000
CY2021 clir Common Stock Issued For Exercise Of Options1.85 Per Share
CommonStockIssuedForExerciseOfOptions1.85PerShare
1.85
CY2021 clir Stock Issued During Period Value Stock Options Exercised1.85 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.85PerShare
6000
CY2021 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
155000
CY2021 clir Common Stock Issued For Exercise Of Options0.98 Per Share
CommonStockIssuedForExerciseOfOptions0.98PerShare
0.98
CY2021 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2021 clir Stock Issued During Period Value Stock Options Exercised0.89 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.89PerShare
55000
CY2021 clir Common Stock Issued For Exercise Of Options1.80 Per Share
CommonStockIssuedForExerciseOfOptions1.80PerShare
1.80
CY2021 clir Shares Issued Upon Exercise Of Warrants
SharesIssuedUponExerciseOfWarrants
67000
CY2021 clir Shares Issued For Services Per Share
SharesIssuedForServicesPerShare
2.33
CY2021 clir Shares Issued For Services2.33 Per Share
SharesIssuedForServices2.33PerShare
26000
CY2021 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7000
CY2021 clir Stock Issued During Period Value In Payments Of Accrued Compensation
StockIssuedDuringPeriodValueInPaymentsOfAccruedCompensation
217000
CY2021 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
262000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
418000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2022 us-gaap Profit Loss
ProfitLoss
-5758000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
26000
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
33000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
373000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
680000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
161000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
260000
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
19000
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
484000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
38000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
131000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
188000
CY2022 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
45000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
251000
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-19000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-53000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
46000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
232000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-121000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-125000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-393000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
360000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
53000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
163000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4992000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6707000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
154000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
140000
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
39000
CY2022 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
5898000
CY2022 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
3337000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2686000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-213000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6539000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5309000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
385000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6539000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5694000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1156000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1217000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6451000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2022 clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
107000
CY2021 clir Officer And Employee Equity Awards For Prior Year Accrued Compensation
OfficerAndEmployeeEquityAwardsForPriorYearAccruedCompensation
217000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6451000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2606000
clir Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
91000000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88500000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4 clir Deferred Tax Assets Prepaid Expenses
DeferredTaxAssetsPrepaidExpenses
-31000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2606000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2022 clir Unrealized Holding Gain On Short Term Investments
UnrealizedHoldingGainOnShortTermInvestments
4000
CY2021 clir Unrealized Holding Gain On Short Term Investments
UnrealizedHoldingGainOnShortTermInvestments
0
CY2022Q4 clir Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
2610000
CY2021Q4 clir Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
0
CY2021Q4 clir Deferred Tax Assets Prepaid Expenses
DeferredTaxAssetsPrepaidExpenses
43000
CY2021 clir Additional Funds Received
AdditionalFundsReceived
44000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3500000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3100000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
759000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1132000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
697000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
1055000
CY2022Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
62000
CY2021Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
77000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
322000
CY2021Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
453000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2022 us-gaap Depreciation
Depreciation
24000
CY2021 us-gaap Depreciation
Depreciation
38000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
186000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
257000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
322000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
133000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
226000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
359000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
555000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2022 us-gaap Payments For Rent
PaymentsForRent
251000
CY2021 us-gaap Payments For Rent
PaymentsForRent
218000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
320000
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
63000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37000
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1122000
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1016000
CY2022Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
101000
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
97000
CY2022Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2021Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1231000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1121000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
433000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
322000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
798000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
147000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
126000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
96000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
61000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
39000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
477000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
374000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
258000
CY2022 clir Cost Of Goods Sold Estimated Loss Upon Completion
CostOfGoodsSoldEstimatedLossUponCompletion
41000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
607000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1059000
CY2021 us-gaap Contract With Customer Asset Change In Method Credit Loss Expense Reversal
ContractWithCustomerAssetChangeInMethodCreditLossExpenseReversal
86000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
247000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
96000
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5000
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10000
CY2021 clir Standard Product Warranty Accrual Adjustments And Other
StandardProductWarrantyAccrualAdjustmentsAndOther
-86000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
337000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
263000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5649000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7686000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-109000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-200000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5758000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7886000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1209000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1657000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-197000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
4000
CY2022 clir Effective Income Tax Reconciliation Prior Year Deferred Tax True Ups
EffectiveIncomeTaxReconciliationPriorYearDeferredTaxTrueUps
-2805000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-82000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
99000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4289000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1558000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
74000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
22000
CY2022Q4 clir Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
102000
CY2022Q4 clir Deferred Tax Assets Accrued Vacation
DeferredTaxAssetsAccruedVacation
-3000
CY2022Q4 clir Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
-16000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20263000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16044000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20726000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16398000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20677000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16388000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
49000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-49000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-10000
CY2022Q4 clir Operating Loss Carryforwards Annual Limitation
OperatingLossCarryforwardsAnnualLimitation
686000
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
62500000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.7764
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.9189
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0139
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0059
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
118000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
425000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2964000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
88000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.26
CY2022 clir Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3D
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
230000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.99
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2779000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M4D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1986000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.70
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1100000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2020Q4 clir Class Of Warrant Or Right Weighted Average Exercise Price Outstanding
ClassOfWarrantOrRightWeightedAverageExercisePriceOutstanding
1.80
CY2021 clir Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
38000
CY2021 clir Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
1.80
CY2021 clir Class Of Warrant Or Right Forfeited Or Expired
ClassOfWarrantOrRightForfeitedOrExpired
43000
CY2021 clir Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Expired
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrExpired
1.80
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
43000
CY2021 clir Agreement Term
AgreementTerm
P10Y
CY2022 clir Governmental Grant Income
GovernmentalGrantIncome
51000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
324000
CY2022Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
50000
CY2022Q3 us-gaap Gross Profit
GrossProfit
123000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-7000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1517000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1660000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1558000
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
1498000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1490000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1638000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1312000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1318000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
363000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
190000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54000
CY2021Q1 us-gaap Gross Profit
GrossProfit
138000
CY2021Q2 us-gaap Gross Profit
GrossProfit
-505000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-88000
CY2021Q4 us-gaap Gross Profit
GrossProfit
3000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2159000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2037000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
2269000
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
1228000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2021000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2290000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2353000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1227000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04

Files In Submission

Name View Source Status
clir-20221231_pre.xml Edgar Link unprocessable
0001558370-23-005285-index-headers.html Edgar Link pending
0001558370-23-005285-index.html Edgar Link pending
0001558370-23-005285.txt Edgar Link pending
0001558370-23-005285-xbrl.zip Edgar Link pending
clir-20221231.xsd Edgar Link pending
clir-20221231x10k.htm Edgar Link pending
clir-20221231x10k001.jpg Edgar Link pending
clir-20221231x10k002.jpg Edgar Link pending
clir-20221231x10k003.jpg Edgar Link pending
clir-20221231xex23d1.htm Edgar Link pending
clir-20221231xex23d1001.jpg Edgar Link pending
clir-20221231xex31d1.htm Edgar Link pending
clir-20221231xex31d2.htm Edgar Link pending
clir-20221231xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
clir-20221231_cal.xml Edgar Link unprocessable
clir-20221231_def.xml Edgar Link unprocessable
clir-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clir-20221231x10k_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending